marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-08-2024
EyePoint Pharmaceuticals Cash and Cash Equivalents 2011-2024 | EYPT
Annual Cash and Cash Equivalents EyePoint Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 281 M | 95.6 M | 179 M | 44.9 M | 22.2 M | 45.3 M | 16.9 M | 15.3 M | 19.1 M | 15.3 M | 6.9 M | 4.62 M | 12.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 281 M | 4.62 M | 58.4 M |
Quarterly Cash and Cash Equivalents EyePoint Pharmaceuticals
| 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90.8 M | 281 M | 133 M | 140 M | 106 M | 95.6 M | 75.4 M | 82.1 M | 102 M | 179 M | 120 M | 128 M | 139 M | 44.9 M | 44.9 M | 44.9 M | 44.9 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 45.3 M | 45.3 M | 45.3 M | 45.3 M | 12.9 M | 11.8 M | 16.9 M | 16.9 M | 11.7 M | 14.3 M | 11.7 M | 14.3 M | 11.2 M | 14.1 M | 11.2 M | 14.1 M | 29.8 M | 11.4 M | 29.8 M | 11.4 M | 15.2 M | 14.5 M | 15.2 M | 14.5 M | 9.41 M | 8.39 M | 9.41 M | 8.39 M | 8.41 M | 9.81 M | 8.41 M | 9.81 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 281 M | 8.39 M | 47.1 M |